PNT

POINT Biopharma Global Inc. Common Stock
PNT

Overview Fund Activity
Delisted

PNT was delisted on the 26th of December, 2023.

Back to rankings

115 hedge funds and large institutions have $455M invested in POINT Biopharma Global Inc. Common Stock in 2023 Q1 according to their latest regulatory filings, with 19 funds opening new positions, 34 increasing their positions, 37 reducing their positions, and 13 closing their positions.

Holders
115
Holders Change
+6
Holders Change %
+5.5%
% of All Funds
1.84%
Holding in Top 10
4
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+33.33%
% of All Funds
0.06%
New
19
Increased
34
Reduced
37
Closed
13
Calls
$66K
Puts
$1K
Net Calls
+$65K
Net Calls Change
+$65K

Top Buyers

1
DTC
1
Deep Track Capital
Connecticut
$17M
2
BI
2
BVF Inc
California
$76.8M
3
PC
3
Pier Capital
Connecticut
$6.27M
4
GPP
4
Great Point Partners
Connecticut
$24.6M
5
RCMNY
5
Rubric Capital Management (New York)
New York
$19.2M

Top Sellers

1
SCM
1
Suvretta Capital Management
New York
$0
2
PHS
2
PFM Health Sciences
California
$23.3M
3
State Street
3
State Street
Massachusetts
$22.7M
4
PA
4
Perceptive Advisors
New York
$0
5
Millennium Management
5
Millennium Management
New York
$2.11M
Name Market Value Shares Shares
Change 		Shares
Change %
QT
126
Quantbot Technologies
New York
– – -3,705 Closed
Nisa Investment Advisors
127
Nisa Investment Advisors
Missouri
$0 30 – –
Carson Wealth (CWM LLC)
128
Carson Wealth (CWM LLC)
Nebraska
$0 65 – –
Simplex Trading
129
Simplex Trading
Illinois
– – – –
CFGS
130
Concourse Financial Group Securities
Alabama
– – – –
2 3 4 5
6